Public, private investors must fill the void left by venture capitalists

01/10/2013 | Xconomy

Venture capitalists have proven more willing to invest in health care-related software applications than in early-stage medical research, which carries more risk and longer times to return on investment, writes consultant Stewart Lyman. Alliances between Big Pharma and academic institutions, patient group investment units, public funding for research, tax breaks and prizes help encourage research. "Fighting disease isn’t just a good investment in our health; it’s also an excellent investment in our economy," Lyman writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX